Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
Public ClinicalTrials.gov record NCT00116389. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Phase 2 Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the 6-month survival rate and safety of talabostat and gemcitabine in patients with stage IV adenocarcinoma of the pancreas.
Study identification
- NCT ID
- NCT00116389
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 8, 2007
United States locations
- U.S. sites
- 28
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Alabama Cancer Center, PC | Florence | Alabama | 35630 | — |
| Northwest Alabama Cancer Center, PC | Muscle Shoals | Alabama | 35661 | — |
| Oncology Associates, PC | Hartford | Connecticut | 06106 | — |
| Palm Beach Institute of Hematology and Oncology | Boynton Beach | Florida | 33435 | — |
| Cancer Center of Florida | Ocoee | Florida | 34761 | — |
| Hematology Oncology Associates of Central Brevard | Rockledge | Florida | 32955 | — |
| Gulfcoast Oncology Associates | St. Petersburg | Florida | 33705 | — |
| Yagnesh V. Oza, MD | Mount Vernon | Illinois | 62864 | — |
| Indiana Oncology Hematology Consultants | Indianapolis | Indiana | 46202 | — |
| Cancer Care Center, Inc. | New Albany | Indiana | 47150 | — |
| Medical Oncology LLC | Baton Rouge | Louisiana | 70809 | — |
| Huron Medical Center | Port Huron | Michigan | 48060 | — |
| Billings Clinic | Billings | Montana | 59101 | — |
| Monmouth Medical Center | Long Branch | New Jersey | 07740 | — |
| New York Oncology Hematology/Albany Regional Cancer Center | Albany | New York | 12208 | — |
| Hematology-Oncology Associates of Rockland | New City | New York | 10956 | — |
| Dayton Oncology and Hematology | Kettering | Ohio | 45409 | — |
| Lawrence M. Stallings, MD | Wooster | Ohio | 44691 | — |
| Trilogy Cancer Center | Wooster | Ohio | 44691 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213-2933 | — |
| Oregon Clinic, The | Portland | Oregon | 97213 | — |
| Cancer Center of the Carolinas | Greenville | South Carolina | 29615 | — |
| Mary Crowley Medical Research Center | Dallas | Texas | 75201 | — |
| Texas Oncology, PA, Presbyterian | Dallas | Texas | 75231 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Elkins Pancreas Center | Houston | Texas | 77030 | — |
| Saint Luke's Episcopal Hospital | Houston | Texas | 77030 | — |
| Cancer Care Northwest | Spokane | Washington | 99218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00116389, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2007 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00116389 live on ClinicalTrials.gov.